Triple-negative breast cancer (TNBC), characterized by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2), is a heterogeneous subtype of epithelial breast tumor. This evidence concerns the gene PGR and triple-negative breast carcinoma.